New York State Common Retirement Fund Purchases 17,278 Shares of Integer Holdings Corporation (NYSE:ITGR)

New York State Common Retirement Fund lifted its position in shares of Integer Holdings Corporation (NYSE:ITGR) by 7.4% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 249,847 shares of the medical equipment provider’s stock after acquiring an additional 17,278 shares during the period. New York State Common Retirement Fund’s holdings in Integer were worth $29,484,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Raymond James Financial Inc. bought a new position in Integer in the 4th quarter valued at approximately $38,073,000. Vaughan Nelson Investment Management L.P. bought a new position in Integer in the 1st quarter valued at approximately $33,337,000. Capital Research Global Investors lifted its stake in Integer by 16.0% in the 4th quarter. Capital Research Global Investors now owns 1,410,803 shares of the medical equipment provider’s stock valued at $186,960,000 after purchasing an additional 194,895 shares during the last quarter. Artisan Partners Limited Partnership bought a new position in Integer in the 4th quarter valued at approximately $22,775,000. Finally, GAMMA Investing LLC lifted its stake in Integer by 8,697.6% in the 1st quarter. GAMMA Investing LLC now owns 78,123 shares of the medical equipment provider’s stock valued at $92,190,000 after purchasing an additional 77,235 shares during the last quarter. Institutional investors own 99.29% of the company’s stock.

Integer Trading Down 0.3%

ITGR opened at $119.61 on Tuesday. Integer Holdings Corporation has a twelve month low of $104.93 and a twelve month high of $146.36. The company has a quick ratio of 2.14, a current ratio of 3.40 and a debt-to-equity ratio of 0.78. The company has a fifty day moving average of $119.91 and a 200-day moving average of $124.82. The stock has a market cap of $4.17 billion, a PE ratio of 56.69, a price-to-earnings-growth ratio of 1.03 and a beta of 0.98.

Integer (NYSE:ITGR) last posted its quarterly earnings data on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share for the quarter, topping the consensus estimate of $1.27 by $0.04. Integer had a net margin of 4.38% and a return on equity of 11.95%. The company had revenue of $437.39 million during the quarter, compared to analysts’ expectations of $428.51 million. During the same period in the prior year, the company posted $1.14 earnings per share. Integer’s revenue for the quarter was up 7.3% compared to the same quarter last year. On average, sell-side analysts predict that Integer Holdings Corporation will post 6.01 EPS for the current year.

Analyst Ratings Changes

ITGR has been the subject of several research reports. Raymond James Financial increased their price objective on shares of Integer from $145.00 to $150.00 and gave the company an “outperform” rating in a research note on Friday, April 25th. KeyCorp dropped their price target on shares of Integer from $154.00 to $145.00 and set an “overweight” rating for the company in a research note on Monday, April 21st. Truist Financial set a $150.00 price target on shares of Integer and gave the company a “buy” rating in a research note on Friday, April 25th. Wall Street Zen raised shares of Integer from a “sell” rating to a “hold” rating in a research note on Monday, May 19th. Finally, Citigroup raised shares of Integer from a “hold” rating to a “strong-buy” rating and raised their price target for the company from $133.00 to $140.00 in a research note on Thursday, May 22nd. Two equities research analysts have rated the stock with a hold rating, seven have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $145.00.

Insider Transactions at Integer

In other Integer news, Director Donald J. Spence sold 14,739 shares of the firm’s stock in a transaction on Wednesday, June 4th. The shares were sold at an average price of $120.38, for a total value of $1,774,280.82. Following the completion of the sale, the director directly owned 18,781 shares in the company, valued at approximately $2,260,856.78. This trade represents a 43.97% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Martin C. Maxwell sold 8,720 shares of the firm’s stock in a transaction on Thursday, June 5th. The stock was sold at an average price of $120.56, for a total transaction of $1,051,283.20. Following the completion of the sale, the director owned 22,170 shares of the company’s stock, valued at $2,672,815.20. The trade was a 28.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 362,434 shares of company stock worth $44,577,115 over the last three months. 2.16% of the stock is owned by company insiders.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.